HKU COVID-19 vaccine trials to start in July
Share - WeChat
A COVID-19 vaccine developed by the University of Hong Kong is expected to begin human trials in July, according to He Yiwu, who leads the HKU vaccine team. However, he told China Daily on Monday that border control could slow down the vaccine manufacturing process as the city must rely on mainland manufacturers. He called for a green channel to facilitate mainland-Hong Kong collaboration in vaccine development.
- Xi presents orders to promote two military officers to rank of general
- New penalties planned for violations related to radioactive waste management
- Best practices in youth cultural exchange released at Chongqing conference
- Yearender: China's 2025 space endeavors have seen new milestones
- HR conference sparks discussion on talent potentials in AI era
- Exhibition of entries for 6th China animal specimen competition opens in Shanghai
































